AT514780T

Compositions for the treatment and diagnosis of breast cancer and methods for their use

Abstract

[Subject] Offer the compound and method for the medical treatment of cancer like a breast cancer, and diagnosis. [Solution means] This Ganke 合物 may contain the polynucleotide which carries out the code of one or more breast tumor protein, its immunogenicity portion, or such portions. Or a medical treatment composite may contain a specific T-lymph cell in the antigen presenting cells which reveal breast tumor protein, or the cell which reveals such protein. Such a composite may be used for, for example, accumulating in prevention and disposal of a disease like a breast cancer. The diagnostic method based on the process of detecting mRNA which carries out the code of breast tumor protein or such protein is also offered. [Selection figure] Nothing

Term

Term ended

Expired 15 February 2020, 6.6 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

82 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
28548099United States of AmericaA
33933899United States of AmericaA
38968199United States of AmericaA
43382699United States of AmericaA
0005308United States of AmericaW

Members82

Family members, oldest first
DocumentOfficeKind
CA2365221A1CanadaA1
WO0060076A2World Intellectual Property Organization (WIPO)A2
AU4005200AAustraliaA
NO20014769D0NorwayD0
CA2406213A1CanadaA1
WO0179286A2World Intellectual Property Organization (WIPO)A2
AU5536901AAustraliaA
NO20014769LNorwayL
WO0060076A3World Intellectual Property Organization (WIPO)A3
BR0009537ABrazilA
KR20020007348ARepublic of KoreaA
EP1183348A2European Patent Office (EPO)A2
MXPA01009956AMexicoA
US6387697B1United States of AmericaB1
US2002064872A1United States of AmericaA1
CN1354791AChinaA
HU0200763A2HungaryA2
HUP0200763A2HungaryA2
IL145620A0IsraelA0
US2002085998A1United States of AmericaA1
US2002102602A1United States of AmericaA1
TR2001003560T2TürkiyeT2
TR200103560T2TürkiyeT2
NO20024972D0NorwayD0
US2002150581A1United States of AmericaA1
WO02083956A1World Intellectual Property Organization (WIPO)A1
JP2002540789AJapanA
NO20024972LNorwayL
US2003023036A1United States of AmericaA1
WO0179286A3World Intellectual Property Organization (WIPO)A3
HK1047134AHong Kong, ChinaA
HK1047134A1Hong Kong, ChinaA1
US6518237B1United States of AmericaB1
US6528054B1United States of AmericaB1
EP1299417A2European Patent Office (EPO)A2
MXPA02010244AMexicoA
ZA200108065BSouth AfricaB
IL152221A0IsraelA0
US6573368B2United States of AmericaB2
US2003104366A1United States of AmericaA1
US6579973B1United States of AmericaB1
US6586572B2United States of AmericaB2
US6590076B1United States of AmericaB1
US2003166022A1United States of AmericaA1
PL353246A1PolandA1
US2003229020A1United States of AmericaA1
US6680197B2United States of AmericaB2
BR0110091ABrazilA
RU2002130715ARussian FederationA
ZA200208365BSouth AfricaB
HU0301740A2HungaryA2
HUP0301740A2HungaryA2
US6756477B1United States of AmericaB1
JP2004520802AJapanA
NZ514351ANew ZealandA
NZ521865ANew ZealandA
PL365244A1PolandA1
US6844325B2United States of AmericaB2
CN1646563AChinaA
US6958361B2United States of AmericaB2
US6969518B2United States of AmericaB2
US2006069054A1United States of AmericaA1
AU784688B2AustraliaB2
US2008200386A1United States of AmericaA1
US2008206250A1United States of AmericaA1
US2008207486A1United States of AmericaA1
US2008207511A1United States of AmericaA1
US2008207547A1United States of AmericaA1
US2008207548A1United States of AmericaA1
US2008227739A1United States of AmericaA1
RU2344831C2Russian FederationC2
US7598226B2United States of AmericaB2
JP2010239970AJapanA
US7855271B2United States of AmericaB2
US2011104211A1United States of AmericaA1
EP1183348B1European Patent Office (EPO)B1
AT514780TThis recordAustriaT
ATE514780T1AustriaT1
JP4806124B2JapanB2
ES2368899T3SpainT3
US8182823B2United States of AmericaB2
JP5053497B2JapanB2